HNN3.0
Register
Register
Register

Aisthesis Medical

Start-up

aisthesismed.com/London, United Kingdom

About

Aisthesis Medical is a medtech company committed to transforming acute care through disruptive AI-based diagnostic solutions. Founded by a team of interdisciplinary scientists and experts in biomedical engineering, data science, and clinical practice, Aisthesis Medical leverages predictive analytics and digital twin technology to revolutionize the management of critical health conditions within hospitals.

Our flagship product, VIOSync, is a state-of-the-art clinical decision-support software system designed to predict sepsis and multi-organ dysfunction up to 48 hours in advance. By utilizing real-time patient data and predictive machine learning algorithms, VIOSync enables rapid initiation of  diagnostic and preventive treatment protocols, significantly improving patient outcomes in emergency rooms and medical-surgical wards. The platform provides data-driven insights that support clinicians in making informed decisions, thereby optimizing resource allocation and patient care strategies.

Representatives

CEO

Aisthesis Medical

Marketplace (2)

  • Project cooperation

    AI-Driven Digital Health Platform for Predictive, Preventive, and Personalised Care

    Looking for research and clinical partners to co-develop and validate AI-driven digital health solutions for predictive and preventive care.

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
    Author

    CEO at Aisthesis Medical

    London, United Kingdom

  • Project cooperation

    VIOSync®: An AI-Driven Clinical Decision Support System for Early Risk Detection and Proactive Care

    Seeking project partners to co-develop and validate AI-driven solutions for early detection, prevention, and personalised care.

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
    Author

    CEO at Aisthesis Medical

    London, United Kingdom